Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VTYX
DateTimeSourceHeadlineSymbolCompany
30/12/202422:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
27/12/202421:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
19/12/202423:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
19/12/202423:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
19/12/202423:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
11/12/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
26/11/202402:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
18/11/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VTYXVentyx Biosciences Inc
15/11/202421:59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202422:13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VTYXVentyx Biosciences Inc
07/11/202421:58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
07/11/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
07/11/202421:05GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
15/10/202412:00GlobeNewswire Inc.Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024NASDAQ:VTYXVentyx Biosciences Inc
30/09/202420:40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTYXVentyx Biosciences Inc
23/09/202412:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
23/09/202412:00GlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
09/09/202420:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/09/202412:00GlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
30/08/202412:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
30/08/202412:00GlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
28/08/202412:00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
13/08/202420:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
13/08/202420:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
08/08/202420:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
08/08/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
08/08/202420:01GlobeNewswire Inc.Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
29/07/202412:00GlobeNewswire Inc.Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
11/06/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/06/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

Your Recent History

Delayed Upgrade Clock